发明授权
US07514426B2 Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
有权
取代的咪唑[1,5-A] [1,2,4]三唑并[1,5-D] [1,4]苯并二氮杂衍生物
- 专利标题: Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
- 专利标题(中): 取代的咪唑[1,5-A] [1,2,4]三唑并[1,5-D] [1,4]苯并二氮杂衍生物
-
申请号: US11252025申请日: 2005-10-17
-
公开(公告)号: US07514426B2公开(公告)日: 2009-04-07
- 发明人: Henner Knust , Andrew William Thomas
- 申请人: Henner Knust , Andrew William Thomas
- 申请人地址: US NJ Nutley
- 专利权人: Hoffman-La Roche Inc.
- 当前专利权人: Hoffman-La Roche Inc.
- 当前专利权人地址: US NJ Nutley
- 代理商 George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
- 优先权: EP04105169 20041020
- 主分类号: A61P25/28
- IPC分类号: A61P25/28 ; A61K31/55 ; C07D243/00
摘要:
The present invention is concerned with substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of formula I wherein R1 is hydrogen, halogen, lower alkyl, lower alkynyl, cycloalkyl, heterocycloalkyl, benzyl, cyano, lower alkoxy, OCF3, —NHR, —NHC(O)R or —NHSO2R; R2 is lower alkyl substituted by halogen; R3 is hydrogen, methyl or aryl; R is lower alkyl, cycloalkyl or aryl; and pharmaceutically acceptable acid addition salts thereof.